Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/112790
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaru, S.-
dc.contributor.authorByrnes, J.-
dc.contributor.authorCarrington, M.-
dc.contributor.authorStewart, S.-
dc.contributor.authorScuffham, P.-
dc.date.issued2015-
dc.identifier.citationExpert Review of Pharmacoeconomics and Outcomes Research: informing decision-making in the delivery of cost-effective healthcare, 2015; 15(4):657-666-
dc.identifier.issn1473-7167-
dc.identifier.issn1744-8379-
dc.identifier.urihttp://hdl.handle.net/2440/112790-
dc.description.abstractSubstantial variation in economic analyses of cardiovascular disease management programs hinders not only the proper assessment of cost-effectiveness but also the identification of heterogeneity of interest such as patient characteristics. The authors discuss the impact of reporting and methodological variation on the cost-effectiveness of cardiovascular disease management programs by introducing issues that could lead to different policy or clinical decisions, followed by the challenges associated with net intervention effects and generalizability. The authors conclude with practical suggestions to mitigate the identified issues. Improved transparency through standardized reporting practice is the first step to advance beyond one-off experiments (limited applicability outside the study itself). Transparent reporting is a prerequisite for rigorous cost-effectiveness analyses that provide unambiguous implications for practice: what type of program works for whom and how.-
dc.description.statementofresponsibilityShoko Maru, Joshua Byrnes, Melinda J Carrington, Simon Stewart and Paul A Scuffham-
dc.language.isoen-
dc.publisherTaylor & Francis-
dc.rights© 2015 Informa UK Ltd-
dc.source.urihttp://dx.doi.org/10.1586/14737167.2015.1046842-
dc.subjectCardiovascular disease; cost-effectiveness; disease management; economic evaluation; heart failure-
dc.titleEconomic implications of cardiovascular disease management programs: moving beyond one-off experiments-
dc.typeJournal article-
dc.identifier.doi10.1586/14737167.2015.1046842-
pubs.publication-statusPublished-
dc.identifier.orcidStewart, S. [0000-0001-9032-8998]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.